In a study of the potential usefulness of quantitative methods for identifying heterozygous serum alpha1-antitrypsin genetic types that may be associated with chronic pulmonary disease, wide ranges of serum alph1-antitrypsin function and concentration were found in series of samples of protease inhibitor (Pi) types MM, MS and MZ samples. Ranges were wider in a group of 99 patients with obstructive pulmonary disease than in 106 normal adults, and demonstrated a greater overlap of types MS and MZ with type MM. Measurement of alpha1-antitrypsin function or concentration cannot be expected to detect Pi types MZ or MS reliably; quantitative screening methods must be accompanied by Pi typing analysis.
No takes yet. Share an insight, caveat, or question.
Talamo et al. (1972) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: